# FDA Inspection 735922 - Exel Inc. D/B/A DHL Supply Chain (USA) - July 22, 2011

Source: https://www.keypedia.com/records/fda_inspections/exel-inc-dba-dhl-supply-chain-usa/0be74de8-82d5-4df1-8d4f-8fede0d62a4a
Source feed: FDA_Inspections

> FDA Inspection 735922 for Exel Inc. D/B/A DHL Supply Chain (USA) on July 22, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 735922
- Company Name: Exel Inc. D/B/A DHL Supply Chain (USA)
- Inspection Date: 2011-07-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1102673 - 2019-05-29](https://www.keypedia.com/records/fda_inspections/exel-inc-dba-dhl-supply-chain-usa/ec8e2424-73c6-484a-bd90-56bbc42f4b6b)
- [FDA Inspection 592418 - 2009-06-04](https://www.keypedia.com/records/fda_inspections/exel-inc-dba-dhl-supply-chain-usa/83a6fd20-d820-4b0c-8cb1-efa54bdf4769)

Company: https://www.keypedia.com/companies/exel-inc-dba-dhl-supply-chain-usa/c712245a-fdad-4e7a-8c8e-ad511f14037f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c